Lourdes Guerrios to Prostate-Specific Antigen
This is a "connection" page, showing publications Lourdes Guerrios has written about Prostate-Specific Antigen.
Connection Strength
0.300
-
Guerrios-Rivera L, Howard LE, Wiggins EK, Hoyo C, Grant DJ, Erickson TR, Ithisuphalap J, Freedland AR, Vidal AC, Fowke JH, Freedland SJ. Metabolic syndrome is associated with aggressive prostate cancer regardless of race. Cancer Causes Control. 2023 Mar; 34(3):213-221.
Score: 0.202
-
Tolksdorf J, Kattan MW, Boorjian SA, Freedland SJ, Saba K, Poyet C, Guerrios L, De Hoedt A, Liss MA, Leach RJ, Hernandez J, Vertosick E, Vickers AJ, Ankerst DP. Multi-cohort modeling strategies for scalable globally accessible prostate cancer risk tools. BMC Med Res Methodol. 2019 10 15; 19(1):191.
Score: 0.041
-
Ankerst DP, Straubinger J, Selig K, Guerrios L, De Hoedt A, Hernandez J, Liss MA, Leach RJ, Freedland SJ, Kattan MW, Nam R, Haese A, Montorsi F, Boorjian SA, Cooperberg MR, Poyet C, Vertosick E, Vickers AJ. A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts. Eur Urol. 2018 08; 74(2):197-203.
Score: 0.037
-
Negr?n R, V?squez A, Nieves M, Guerrios L, Irizarry-Ram?rez M. Body mass index affects the diagnosis and progression of prostate cancer in Hispanics. Ethn Dis. 2010; 20(1 Suppl 1):S1-168-72.
Score: 0.021